SCHEMBL21034890

SCHEMBL21034890

c1ccc(-c2ccc3c(c2)c2ccccc2c2c4ccc(-c5cccc6c(-c7ccc8oc9ccccc9c8c7)cccc56)cc4c4ccccc4c32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.46
PLA2G4A P47712 5/20 0.46
PLA2G10 O15496 1/20 0.44
ALOX5 P09917 1/20 0.43
HPGD P15428 3/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
AHR P35869 2/20 0.38
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
PRKDC P78527 2/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21034887 0.96 PLA2G2A (0.47) PLA2G2APLA2G4APLA2G10ALOX5HPGD
SCHEMBL21035453 0.94 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5HPGD
SCHEMBL21035278 0.94 ALOX5 (0.47) PLA2G2APLA2G4APLA2G10ALOX5HPGD
SCHEMBL21035276 0.93 PLA2G2A (0.51) PLA2G2APLA2G4APLA2G10HPGDKDM4E
SCHEMBL21035274 0.93 PLA2G2A (0.51) PLA2G2APLA2G4APLA2G10HPGDKDM4E
SCHEMBL20698116 0.91 ALOX5 (0.44) PLA2G2APLA2G4APLA2G10ALOX5HPGD
SCHEMBL21034889 0.90 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5HPGD
SCHEMBL21035454 0.90 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ALOX5HPGD
SCHEMBL21034881 0.90 MAPT (0.47) PLA2G2APLA2G4APLA2G10ALOX5HPGD
SCHEMBL16133247 0.90 PLA2G2A (0.49) PLA2G2APLA2G4APLA2G10ALOX5HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT JNC CORPORATION (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT TCF4, LGR4, OR51E2 PLA2G2A 2960/4885PLA2G4A 2931/4885PLA2G10 2966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.